Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 11;17(1):18914.
doi: 10.7448/IAS.17.1.18914. eCollection 2014.

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

Affiliations

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

Steve Innes et al. J Int AIDS Soc. .

Abstract

Objective: To describe the degree of HIV disease progression in infants initiating antiretroviral therapy (ART) by three months of age in a programmatic setting in South Africa.

Design: This was a programmatic cohort study.

Methods: Electronic and manual data extraction from databases and antiretroviral registers in 20 public clinics in Cape Town and electronic data extraction from a large ART service at Chris Hani Baragwanath Hospital in Soweto were performed. Records of all infants initiated on ART by three months of age between June 2007 and September 2010 were extracted. Demographics, immunological and clinical stage at ART initiation were analyzed descriptively by chi-square, two-sample t-test and Kaplan-Meier methods.

Results: A total of 403 records were identified: 88 in Cape Town and 315 in Soweto. Median age at ART initiation was 8.4 [interquartile range (IQR): 7.2-9.7] weeks. At ART initiation, 250 infants (62%) had advanced HIV disease (CD4% <25% or absolute CD4<1500 cells/mm(3) or WHO clinical Stage 3 or 4). Median age at ART initiation by site was 10.3 (IQR: 8.2-11.9) weeks in Cape Town and 8.6 (IQR: 7.7-10.0) weeks in Soweto infants (p<0.0001). In Cape Town, 73 infants (83%) had advanced HIV disease at ART initiation, compared to 177 infants (56%) in Soweto (p<0.0001). On logistic regression, each month increase in age at ART initiation lowered the odds of initiating ART in an optimal state (OR: 0.56, CI: 0.36-0.94) and increased the odds of advanced HIV disease at ART initiation (OR: 1.69, CI: 1.05-2.71).

Conclusions: ART initiation by three months of age may not adequately prevent disease progression. New emphasis on early diagnosis and rapid initiation of ART in the first weeks of life are essential to further reduce infant mortality.

Keywords: South Africa; antiretroviral therapy; early infant diagnosis; infant HIV; programmatic cohort.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mortality by 24 weeks of age in infants who were successfully initiated on ART before three months of age.* *Infants who died or were lost to follow-up before ART could be initiated, or who were initiated on ART after three months of age were not included.
Figure 2
Figure 2
Loss-to-follow-up at the date of data extraction.* *Infants who died or were lost to follow-up before ART could be initiated, or who were initiated on ART after three months of age were not included.

References

    1. UNAIDS, World Health Organization. UNICEF. GLOBAL HIV/AIDS RESPONSE Progress Report 2011: epidemic update and health sector progress towards universal access. Geneva: WHO Press; 2011.
    1. Goga A, Dinh T, Jackson D, for the SAPMTCTE study group . Pretoria: South African Medical Research Council, National Department of Health of South Africa, and PEPFAR/US Centers for Disease Control and Prevention. 2012. Evaluation of the effectiveness of the national prevention of mother-to-child transmission (PMTCT) programme measured at six weeks postpartum in South Africa, 2010.
    1. Sherman G, Lilian R. Early infant diagnosis of HIV infection in South Africa: 2008 to 2010. Johannesburg: National Health Laboratory Service; 2011.
    1. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233–44. - PMC - PubMed
    1. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, 3rd, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345(21):1522–8. - PubMed

Publication types

Substances